Our platform exposes secrets hiding in the options market. Unusual options activity tracking to catch where the smart money is quietly positioning. Hidden bets and sentiment indicators that precede major price moves.
Serina Therapeutics Inc. (SER), a clinical-stage biotechnology company focused on the development of novel polymer-based drug delivery technologies, experienced a modest decline in recent trading sessions. The stock traded at $1.75 per share, reflecting a decrease of approximately 3.31% during the period under review. This pullback places the shares within a well-defined trading range, with key technical levels drawing attention from market participants. The biotechnology sector has demonstrated
How Serina Therapeutics (SER) responds when competition intensifies (Volatility Increases) 2026-05-08 - Call Flow Alert
SER - Stock Analysis
3608 Comments
1905 Likes
1
Kyliann
Daily Reader
2 hours ago
Nothing short of extraordinary.
👍 241
Reply
2
Edgard
Active Contributor
5 hours ago
I wish I didn’t rush into things.
👍 241
Reply
3
Manshi
Loyal User
1 day ago
Indices are testing support levels, which may provide a base for potential upward moves.
👍 286
Reply
4
Joanel
Elite Member
1 day ago
I’m not sure what I just agreed to.
👍 223
Reply
5
Courtne
Loyal User
2 days ago
Expert US stock picks delivered daily with complete analysis and risk assessment to support informed investment decisions across all market conditions. Our recommendations span multiple time horizons and investment styles to accommodate different risk tolerances and financial goals. We provide sector analysis, earnings forecasts, and technical charts to support your investment strategy. Access professional-grade picks and analysis to achieve consistent portfolio growth and optimize your investment performance.
👍 252
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.